Intravitreal and subretinal injection of tissue plasminogen activator (tPA) in the treatment of experimentally created retinal vein occlusion in rabbits.

To evaluate the effectiveness of intravitreal or subretinal injection of tPA in the treatment of experimentally created retinal vein occlusion (RVO) in rabbits.
Fifteen rabbits were included in this study. RVO was created in all using an argon green laser following intravenous injection of rose Bengal. Follow-up examinations included color fundus photography, fundus fluorescein angiography, and optical coherence tomography. Following examinations at day 2, animals were divided into three groups: six rabbits were kept as control, four rabbits received subretinal injection of tPA, and five rabbits received intravitreal tPA.
Of 14 eyes that had capillary drop out at day 2 following creation of RVO, 12 remained the same at week 3. Only one eye in the control group and one eye in the subretinal group developed complete reperfusion of capillaries. Although there was more revascularization in all groups at week 3, there was not a significant difference in the amount of revascularization between the control group and those animals receiving subretinal or intravitreal tPA.
Intravitreal or subretinal injection of tPA 2 days following vein occlusion did not improve reperfusion of retinal vessels in experimentally created RVO in rabbits when compared to control group.
AuthorsHossein Ameri, June-Gone Kim, Tanapat Ratanapakorn, Gerald J Chader, Mark S Humayun
JournalRetina (Philadelphia, Pa.) (Retina) Vol. 28 Issue 2 Pg. 350-5 (Feb 2008) ISSN: 0275-004X [Print] United States
PMID18301042 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Fibrinolytic Agents
  • Tissue Plasminogen Activator
  • Animals
  • Disease Models, Animal
  • Fibrinolytic Agents (administration & dosage)
  • Fluorescein Angiography
  • Injections
  • Rabbits
  • Retinal Vein Occlusion (diagnosis, drug therapy, physiopathology)
  • Tissue Plasminogen Activator (administration & dosage)
  • Tomography, Optical Coherence
  • Treatment Outcome
  • Vitreous Body

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: